An article of Dr. Paul P. Potnuru will be published in the November 2022 edition of the Journal of Clinical Anesthesia, titled “Impact of Cesarean versus Vaginal Delivery on the Risk of Postpartum Acute Kidney Injury: A Retrospective Database Controlled Study in 116,876 Parturients”. This caught the great attention that the journal companied with a very important editorial by Dr. M. Van de Velde from Belgium.
It is well recognized that the rate of Cesarean delivery (CD) is high and keeps rising globally. In a certain country, the rate of CD is over 70%. It is also well known that the rate of CD higher than 19% does not correlate with improved maternal or neonatal outcomes and the opposite is true. The driving force of high and continuously raising rate of CD are multifactorial. However, the sense of CD being safe seems a great contributing factor to the decision-making process of providers, parturients, and their families. Such a notion has not been systemically and scientifically assessed due to the lack of randomized trials to compare the outcome of CD versus vaginal delivery (VD). Dr. Potnuru et al demonstrated the greater intrinsic risk of CD versus VD. Even though this study is not a randomized clinical trial, it included over 100,000 parturients, utilized a restricted matching method, and underwent sophisticated sensitivity analysis and make the health conditions and peripartum interventions of the two groups, CD versus VD, as much as comparable. The study design is robust and the evidence is trustful. Dr. Potnuru and his team concluded is this article that in the context of increasing CD rates and the peripartum risks associated with CD, parturients, families, and healthcare providers must carefully weigh the maternal and neonatal risks when a decision is made to have a cesarean delivery. The take home massage was echoed well in the editorial of Dr. M. Van de Velde.
Congratulation to Dr. Potnuru and the team! We are looking forward to seeing the future success in your career.